Edem Agamah

Dr. Edem Agamah is a Professor in the Division of Hematology/Oncology within the Department of Internal Medicine at the University of Chicago School of Medicine. His clinical expertise spans hematology, oncology, and blood disorders, with specialization in breast cancer, colon cancer, and genetic epidemiology research.

His educational background includes:

• Medical Degree from University of Ghana Medical School, Accra, Ghana
• Residency in Hematology at Korle Bu Teaching Hospital, Accra, Ghana
• Residency in Internal Medicine at St. Francis Hospital, Evanston, IL
• Fellowship in Hematology/Oncology at the University of Chicago, Chicago, IL

Dr. Agamah's research centers on genetic epidemiology and molecular mechanisms of breast and colon cancers. His work investigates genetic predisposition factors and therapeutic responses, aiming to develop precision medicine approaches for cancer treatment. He actively contributes to translational research bridging laboratory findings with clinical applications.

His publication record demonstrates consistent leadership in multi-institutional clinical trials, primarily through the University of Chicago Phase II Consortium and NCI-sponsored studies. These trials span diverse cancer types including prostate, adrenocortical, mesothelioma, pancreatic, and uterine cancers, with emphasis on novel targeted therapies and combination regimens. His work reflects a strategic focus on advancing treatment options for rare and advanced malignancies.

Dr. Agamah collaborates extensively with national research consortia including the University of Chicago Phase II Consortium and NCI-sponsored trials. His clinical trial portfolio features investigator-initiated studies evaluating emerging therapeutics like cixutumumab, darolutamide, and angiogenesis inhibitors across multiple cancer types.